Saudi Arabia’s $600 billion U.S. investment commitment is one factor that could drive upside in 2026, though the outlook for ...

FY 2026 earnings are highly anticipated, but the company's demand outlook is troubling. Click here to find out why NVDA stock ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has ...

Nvidia faces major risks from escalating US-China trade tensions, with Chinese competitors rapidly gaining market share. Read ...

The gross proceeds from the offering, before deducting the underwriting discounts and commissions and offering expenses payable by Outlook Therapeutics are expected to be approximately $13.0 million.

ISELIN, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics ... the treatment of wet age-related macular degeneration (wet AMD), today announce ISELIN, N.J., Feb. 28, 2025 (GLOBE NEWSWIRE ...

Nvidia (NVDA) is gearing up to unveil its first-quarter earnings report for fiscal 2026 on May 28 amidst renewed investor ...

Wedbush expects significant value to be unlocked through Tesla’s full self-driving (FSD) technology and the rollout of its ...

Poor breadth is mirrored in the percentage of total shares traded that are falling versus those rising. On the NYSE, ...

Intel Corporation, Qualcomm Incorporated, Advanced Micro Devices Inc. Read 's Market Analysis on Investing.com ...

Advanced Micro Devices (NASDAQ: AMD) is an important player in the global semiconductor industry as its chips power multiple ...